UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000061896
Receipt number R000070823
Scientific Title Verification of ADH1B and ALDH2 Gene Polymorphisms Affecting Severe Alcoholic Hepatitis: A Multicenter Study
Date of disclosure of the study information 2026/06/13
Last modified on 2026/06/13 16:11:59

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Multicenter Observational Study on the Relationship between Severe Alcoholic Hepatitis and Alcohol-Metabolizing Gene Polymorphisms (ADH1B and ALDH2)

Acronym

SAH-GENE study

Scientific Title

Verification of ADH1B and ALDH2 Gene Polymorphisms Affecting Severe Alcoholic Hepatitis: A Multicenter Study

Scientific Title:Acronym

SAH-GENE study

Region

Japan


Condition

Condition

Severe Alcoholic Hepatitis

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

Severe alcoholic hepatitis (SAH) is a rare and extremely poor-prognosis condition characterized by acute jaundice, marked inflammatory response, and multi-organ failure, occurring in a small subset of patients with alcoholic hepatitis associated with chronic heavy alcohol consumption. A clinically important issue is that "only a fraction of patients with comparable drinking histories develop severe acute-type disease," which highlights the rarity and heterogeneity of this condition.
In East Asian populations, functional polymorphisms in ADH1B and ALDH2, enzymes involved in ethanol metabolism, are highly prevalent and have been reported to influence various disease phenotypes including flushing response, alcohol dependence, and liver injury (Tadokoro, Nakahara, et al. 2025). However, the extent to which these genetic differences in alcohol metabolic capacity, unique to East Asian populations, determine the onset of SAH has not been investigated. The aim of this study is to identify alcohol metabolism gene polymorphisms specific to SAH.

Basic objectives2

Others

Basic objectives -Others

Verification of the association between gene polymorphisms and the risk of SAH onset and severity

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Association between ADH1B low-activity / ALDH2 active genotype and the onset of severe alcoholic hepatitis (SAH)

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients aged 20 years or older hospitalized for alcohol-induced liver injury. Written informed consent obtained.

Key exclusion criteria

Patients who do not provide informed consent for genetic testing. Patients whose primary liver disease is attributed to other etiologies such as HBV, HCV, or autoimmune hepatitis.

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Tomoko
Middle name
Last name Tadokoro

Organization

Kagawa University Faculty of Medicine

Division name

Department of Gastroenterology and Neurology

Zip code

761-0793

Address

1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, Japan

TEL

0878985111

Email

tadokoro.tomoko@kagawa-u.ac.jp


Public contact

Name of contact person

1st name Tomoko
Middle name
Last name Tadokoro

Organization

Kagawa University Faculty of Medicine

Division name

Department of Gastroenterology and Neurology

Zip code

761-0793

Address

1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, Japan

TEL

0878985111

Homepage URL


Email

tadokoro.tomoko@kagawa-u.ac.jp


Sponsor or person

Institute

Kagawa University

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kagawa University Faculty of Medicine Ethics Committee

Address

1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, Japan

Tel

0878985111

Email

tadokoro.tomoko@kagawa-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 06 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2026 Year 04 Month 02 Day

Date of IRB

2026 Year 04 Month 02 Day

Anticipated trial start date

2026 Year 04 Month 02 Day

Last follow-up date

2028 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This is a multicenter observational study without any intervention. Dried saliva samples are collected from patients hospitalized for alcohol-induced liver injury, and ADH1B/ALDH2 genotypes are analyzed by real-time PCR. The association between genotype and the onset/severity of severe alcoholic hepatitis (SAH) will be verified by comparison with GWAS data.


Management information

Registered date

2026 Year 06 Month 13 Day

Last modified on

2026 Year 06 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000070823